|
Inflammation as a target
|
2
|
Resverlogix Corp.
|
Aug 31, 2017 10:50AM
|
|
Next Hurdle
|
2
|
Resverlogix Corp.
|
Jan 05, 2018 11:12AM
|
|
Re: Grand Cayman
|
2
|
Resverlogix Corp.
|
Jan 01, 2023 12:08PM
|
|
Re: Lilly to Discontinue Development of Evacetrapib
|
2
|
Resverlogix Corp.
|
Nov 17, 2015 10:30AM
|
|
Re: Upcoming RVX presentations, human blood microarray & babbling on FACET analysis
|
2
|
Resverlogix Corp.
|
Jul 24, 2015 05:38PM
|
|
Re: What Jardiance/EMPA-REG Outcome means for RVX-208
|
2
|
Resverlogix Corp.
|
Sep 18, 2015 11:27AM
|
|
Re: On the Stockhouse Board this morning
|
1
|
Resverlogix Corp.
|
Aug 21, 2017 12:50PM
|
|
Re: i quote what someboday else posts back to me & I my post gets banned, come on..
|
1
|
Resverlogix Corp.
|
Sep 18, 2015 11:32AM
|
|
Re: BET inhibitor and BRD4 papers keep piling up
|
1
|
Resverlogix Corp.
|
Sep 25, 2017 10:48AM
|
|
Re: Zenith Shareholders
|
1
|
Zenith Epigenetics
|
Sep 01, 2021 04:48PM
|
|
Re: Genentech/Roche BET inhibitor toxicity paper
|
1
|
Resverlogix Corp.
|
Apr 20, 2016 01:09PM
|
|
Cytovance
|
1
|
Resverlogix Corp.
|
Apr 13, 2020 11:34AM
|
|
OTC Trading questions
|
1
|
Zenith Epigenetics
|
Mar 01, 2022 01:02PM
|
|
Re: Looks like 0 participation in warrant incentive imo - answer to my email...
|
1
|
Resverlogix Corp.
|
Jan 17, 2020 09:23PM
|
|
Re: Finance
|
1
|
Resverlogix Corp.
|
Feb 23, 2021 04:50PM
|
|
Re: At least we closed up.....
|
1
|
Resverlogix Corp.
|
Aug 26, 2017 10:30AM
|
|
Re: So, the mood this week was.
|
1
|
Resverlogix Corp.
|
Aug 26, 2021 12:27PM
|
|
Re: Next Hurdle
|
1
|
Resverlogix Corp.
|
Jan 05, 2018 12:26PM
|
|
Re: Has Kenneth Lebioda done presentations before?
|
1
|
Resverlogix Corp.
|
Sep 22, 2017 09:21AM
|
|
Re: kelsee
|
1
|
Resverlogix Corp.
|
May 22, 2019 04:48PM
|
